Skip to main content

Day: March 20, 2025

Assertio to Participate in the iAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025

LAKE FOREST, Ill., March 20, 2025 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O’Grady, Chief Executive Officer, will present at the iAccess Alpha Best Ideas Spring Investment Conference taking place virtually March 25-26, 2025. The Company will present at 1:30 pm Eastern Time on Tuesday, March 25, 2025. To join the presentation, please visit the webcast available online at https://investor.assertiotx.com/. Additionally, investors participating in the conference can request 1×1 meetings to take place on March 26, 2025 via their conference representative or through Assertio investor relations at mkreps@darrowir.com. To register to attend the conference and request 1×1 meetings, please visit https://www.iaccessalpha.com/. About Assertio Assertio is...

Continue reading

FBI Veteran Joseph Bonavolonta Joins Wrap with 27 Years of Experience, Former SAC of Boston Field Office

Expected to Strengthen Global Law Enforcement Network, Enhancing Security and Compliance Capabilities Across Business Intelligence, Critical Infrastructure, Supply Chain and National SecurityMIAMI, March 20, 2025 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or, the “Company”) today announced the appointment of Joseph R. Bonavolonta as Domestic Head of Managed Services of the Company, bringing over 27 years of experience from the Federal Bureau of Investigation (“FBI”) to the Company’s management team. Mr. Bonavolonta, who culminated his distinguished FBI career as Special Agent in Charge (SAC) of the Boston Field Office, led one of the agency’s largest divisions, overseeing high-profile criminal and national security investigations. His leadership extended to managing Joint Terrorism Task Forces, Safe Streets...

Continue reading

Star Equity Holdings, Inc. Announces 2024 Fourth Quarter and Full Year Financial Results

Fourth Quarter Revenues Increased 21% and Gross Profit Increased 56% Generated Fourth Quarter Adjusted EBITDA of $1.1 Million ADT Acquisition Closed in March, Establishing Energy Services Division OLD GREENWICH, Conn, March 20, 2025 (GLOBE NEWSWIRE) — Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified holding company, reported today its financial results for the fourth quarter (Q4) and fiscal year (FY) ended December 31, 2024. All 2024 and 2023 amounts in this release are unaudited. Following the sale of our Digirad Health business on May 4, 2023, all financial results for the 2023 reporting periods, unless stated otherwise, relate to continuing operations, which as of December 31, 2024 included two divisions: Building Solutions and Investments. Following the acquisition of Alliance...

Continue reading

Flourish to Acquire Sora Finance, Creating First Comprehensive Deposits and Lending Platform for RIAs

Strategic Acquisition Brings Mortgage and Liability Optimization Capabilities to Flourish’s Leading WealthTech Platform, Helping Independent Advisors Better Compete with Wirehouses and Banks Through Holistic Service Offering New York, March 20, 2025 (GLOBE NEWSWIRE) — Flourish, a platform that helps registered investment advisors (RIAs) grow by evolving from holistic advice to holistic implementation, today announced that it has entered into a definitive agreement to acquire Sora Finance (Sora), an AI-driven liability optimization platform for advisors. The acquisition creates one of the industry’s first comprehensive platforms addressing both asset and liability management for RIAs, empowering independent advisors to bring cash and lending services to their clients. Sora works with over 750 financial advisors, helping...

Continue reading

Formula Systems Reports Fourth Quarter and Full Year 2024 Financial Results

2024 Full-year revenues increased by 5.2% year over year, reaching a record-breaking $2.76 billion, while net income grew by 24.5% to a record-breaking $79.7 million OR YEHUDA, Israel, March 20, 2025 (GLOBE NEWSWIRE) — Formula Systems (1985) Ltd. (Nasdaq and TASE: FORTY) (“Formula” or the “Company”), a global information technology group engaged, through its subsidiaries and affiliates, in providing software consulting services and computer-based business solutions and developing proprietary software products, today announced its fourth quarter and full year 2024 results of operations. Financial Highlights for the Fourth Quarter Ended December 31, 2024  ● Revenues for the fourth quarter ended December 31, 2024, increased by 8.0% year over year, reaching a fourth quarter record-breaking $691.5 million, compared to $640.3 million...

Continue reading

Academy Sports + Outdoors Reports Fourth Quarter and Fiscal 2024 Results

Fourth Quarter Comparable Sales Declined (3.0)%: a +190 Basis Point Improvement vs. Third Quarter 2024 Fourth Quarter Diluted GAAP EPS of $1.89: Above the Midpoint of Updated Guidance Provided Company Announces Launch of Jordan Brand in 145 Stores and Online Beginning in Late April Quarterly Dividend Increased by 18% Per Share KATY, Texas, March 20, 2025 (GLOBE NEWSWIRE) — Academy Sports and Outdoors, Inc. (Nasdaq: ASO) (“Academy” or the “Company”) today announced its financial results for the fourth quarter and fiscal year ended February 1, 2025. Fourth quarter and fiscal year 2024 included 13 and 52 weeks, respectively, compared to 14 and 53 weeks in fourth quarter and fiscal year 2023, respectively. “Looking back on 2024, our team made significant strides toward achieving our long-term goals, all while...

Continue reading

TOMI Environmental Solutions Selected by NASA for Biosecurity Operation

FREDERICK, Md., March 20, 2025 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions developed through DARPA technology, today announced the deployment of its SteraMist iHP technology at the NASA Johnson Space Center, marking the Company’s expansion into the aerospace sector. TOMI’s SteraMist iHP technology has been selected by NASA in partnership with a U.S. government and commercial services engineering contractor dedicated to mission and defense solutions, including space exploration and scientific discovery. SteraMist iHP is now being utilized in a biosafety cabinet designated for handling samples returned from the Mars Perseverance Rover mission at the NASA Johnson Space Center. This opportunity, facilitated through TOMI’s distributor ARES...

Continue reading

NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues

Conference call will be held today, Thursday, March 20 at 9:00 am ET CARMEL, Ind., March 20, 2025 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the fourth quarter and fiscal year 2024 for the period ended December 31, 2024. 4Q24 Financial highlightsRevenues increased 43% to $761 thousand in 4Q24 compared to $531 thousand in 4Q23. Operating loss improved by 10% compared to the fourth quarter of 2023. Cash balance was $3.7 million as of December 31, 2024.Recent Operational HighlightsExpanded total covered lives to approximately 51 million compared to 4 million as of December 31 2023. Received a new Current Procedural Terminology...

Continue reading

Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans

FDA priority review of pz-cel Biologics License Application (BLA) progressing with Prescription Drug User Fee Act (PDUFA) target action date of April 29, 2025 Launch preparations on track toward goal to treat first patient in 3Q 2025 CLEVELAND, March 20, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the full year of 2024, and announced progress in the ongoing review with the U.S. Food and Drug Administration (FDA) regarding prademagene zamikeracel (pz-cel) and plans for the U.S. commercial launch of pz-cel for recessive dystrophic epidermolysis bullosa (RDEB), if approved. The Company will host a conference call and webcast today at 8:30 a.m. ET. “The RDEB community continues to highlight the unmet medical need for new therapies that could provide long-lasting healing and pain...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.